Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q2 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.13 million versus the consensus estimate of $956.14 thousand.

For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.